{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:26:46Z","timestamp":1787966806308,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cca.2024.120087","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:05:24Z","timestamp":1733789124000},"page":"120087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Standardization of hemoglobin A2 and hemoglobin F: Achievements and perspectives"],"prefix":"10.1016","volume":"567","author":[{"given":"Andrea","family":"Mosca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Arsene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Paleari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Harteveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.120087_b0005","unstructured":"IFCC website: https:\/\/IFCC.org."},{"key":"10.1016\/j.cca.2024.120087_b0010","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"15","author":"Weatherall","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cca.2024.120087_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/jcp.2008.056945","article-title":"The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies","volume":"62","author":"Mosca","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2024.120087_b0020","unstructured":"D.J. Weatherall, The thalassemias: disorders of globin synthesis, in: Williams Hematology, 9th ed., McGraw-Hill, chapter 48 (2016)."},{"key":"10.1016\/j.cca.2024.120087_b0025","doi-asserted-by":"crossref","unstructured":"S. Colaco, R. Colah, A. Nadkarni, Significance of borderline HbA2 levels in \u03b2 thalassemia carrier Screening, Scientific Reports (2022) 12:5414 | https:\/\/doi.org\/10.1038\/s41598-022-09250-5.","DOI":"10.1038\/s41598-022-09250-5"},{"key":"10.1016\/j.cca.2024.120087_b0030","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/bjh.17561","article-title":"Delta-globin gene expression improves sickle cell disease in a humanised mouse model","volume":"193","author":"Porcu","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2024.120087_b0035","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood.2021014877","article-title":"Kruppel-like factor 1\u2013GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo","volume":"140","author":"Zhu","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cca.2024.120087_b0040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1515\/cclm-2012-0575","article-title":"on behalf of the IFCC Working Group on Standardization of HbA2. Analytical goals for the determination of HbA2","volume":"51","author":"Mosca","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2024.120087_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1515\/CCLM.2007.002","article-title":"for the IFCC Working Group \u201cStandardization of HbA2\u201d, External quality assessment of hemoglobin A2 measurement: data from an Italian pilot study with fresh whole blood samples and commercial HPLC systems","volume":"45","author":"Paleari","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2024.120087_b0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1751-553X.2012.01403.x","article-title":"Interlaboratory comparison of current high-performance methods for HbA2","volume":"34","author":"Paleari","year":"2012","journal-title":"Int. J. Lab. Haematol."},{"key":"10.1016\/j.cca.2024.120087_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1751-553X.2011.01367.x","article-title":"on behalf of the International Council for the Standardisation in Heamatology (ICSH), ICSH recommendations for the measurement of haemoglobin F","volume":"34","author":"Stephens","year":"2012","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.cca.2024.120087_b0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjh.14463","article-title":"Elevated fetal haemoglobin is a predictor of better outcome in MDS\/AML patients receiving 5-aza-2\u2019-deoxycytidine (Decitabile)","volume":"176","author":"Lubbert","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2024.120087_b0065","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0140-6736(15)01341-0","article-title":"Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies","volume":"387","author":"Lettre","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2024.120087_b0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa2113206","article-title":"Betibeglogene Autotemcel Gene Therapy for Non-\u03b20\/\u03b20Genotype \u03b2-Thalassemia","volume":"386","author":"Locatelli","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2024.120087_b0075","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"Gbd","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.cca.2024.120087_b0080","unstructured":"UK NEQAS website for abnormal hemoglobins (https:\/\/ukneqas.org.uk\/programmes\/?keyword=pathological+haemoglobins&centre=15#find-a-programme-block)."},{"key":"10.1016\/j.cca.2024.120087_b0085","first-page":"298","article-title":"Standardization of the HbA2 assay","volume":"29","author":"Paleari","year":"2018","journal-title":"eJIFCC"},{"key":"10.1016\/j.cca.2024.120087_b0090","unstructured":"A. Henrion, C.G. Arsene, M. Leibl, G. O\u2019Connor, Label-free quantification of host cell protein impurity in."},{"key":"10.1016\/j.cca.2024.120087_b0095","unstructured":"W. I. Burkitt, C. Pritchard, C. Arsene, A. Henrion, D. Bunk, G. O\u2019Connor, Toward Syst\u00e8me International."},{"key":"10.1016\/j.cca.2024.120087_b0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ab.2010.08.037","article-title":"Quantification of protein calibrants by amino acid analysis using isotope dilution mass spectrometry","volume":"408","author":"Mu\u00f1oz","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cca.2024.120087_b0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2018.10.024","article-title":"on behalf of the IFCC Working Group on Standardisation of Hemoglobin A2 (WG-HbA2). Determination of HbA2 by quantitative bottom-up proteomics and isotope dilution mass spectrometry","volume":"487","author":"Arsene","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2024.120087_b0110","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1515\/CCLM.2010.317","article-title":"on behalf of the IFCC Working Group on Standardization of HbA2 (WG-HbA2), Towards the development of a certified reference material for hemoglobin A2","volume":"48","author":"Paleari","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2024.120087_b0115","unstructured":"G. Auclair, A. Mu\u00f1oz-Pi\u00f1eiro, J. Charoud-Got, R. Paleari, P. Kaiser, C. Arsene, S. Trapmann, A. Mosca, L. Deprez, Certification of the amount-of-substance fraction of haemoglobin A2 versus total haemoglobin in blood haemolysate: ERM\u00ae-DA485\/IFCC and ERM\u00ae-DA486\/IFCC. European Commission, Joint Research Center Reference materials report, ISBN 978-92-68-14954-6 doi:10.2760\/877530."},{"key":"10.1016\/j.cca.2024.120087_b0120","unstructured":"A. Lamberty, H. Schimmel, J. Pauwels, The study of the stability of reference materials by isochronous."},{"key":"10.1016\/j.cca.2024.120087_b0125","unstructured":"G. Nilsson, J.R. Budd, N. Greenberg, V. Delatour, R. Rej, M. Panteghini, F. Ceriotti, H. Schimmel, C. Weykamp, T. Keller, J.E. Camara, C Burns, H.W. Vesper, F. MacKenzie, W.G. Miller, IFCC Working Group recommendations for."},{"key":"10.1016\/j.cca.2024.120087_b0130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1373\/clinchem.2017.277558","article-title":"IFCC Working Group recommendations for assessing commutability part 3: using the calibration effectiveness of a reference material","volume":"64","author":"Budd","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2024.120087_b0135","unstructured":"ISO 17034:2016. General requirements for the competence of reference material producers, International Organization for Standardization, Geneva, Switzerland."},{"key":"10.1016\/j.cca.2024.120087_b0140","unstructured":"ISO 33405:2024. Reference materials \u2013 Approaches for characterization and assessment of homogeneity and stability, International Organization for Standardization, Geneva, Switzerland."},{"key":"10.1016\/j.cca.2024.120087_b0145","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood.V75.10.2070.2070","article-title":"Characterization of two types of fetal hemoglobin: \u03b12G\u03b32 and \u03b12A\u03b32","volume":"75","author":"Adachi","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cca.2024.120087_b0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/03630269809071544","article-title":"Gamma chains heterogeneity: determination of HbF composition by perfusion chromatography","volume":"22","author":"Papassotiriou","year":"1998","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cca.2024.120087_b0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2020.11.008","article-title":"on behalf of the IFCC ICSH Joint Working Group for standardization of HbA2, A roadmap for the standardization of hemoglobin A2","volume":"512","author":"Mosca","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2024.120087_b0160","unstructured":"M. Vidali, R. Paleari, F. Ceriotti, S. Bernardini, I. Giambini, D. Brugnoni, L. Trainini, C. Carru, F. Porcu, M. Carta."},{"key":"10.1016\/j.cca.2024.120087_b0165","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/dta.2350","article-title":"Growth Hormone Isoform-Differential Mass Spectrometry for Doping Control Purposes","volume":"10","author":"Arsene","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"10","key":"10.1016\/j.cca.2024.120087_b0170","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1021\/acs.analchem.1c03061","article-title":"Candidate High-Resolution Mass Spectrometry-Based Reference Method for the Quantification of Procalcitonin in Human Serum Using a Characterized Recombinant Protein as a Primary Calibrator","volume":"94","author":"Huynh","year":"2022","journal-title":"Anal Chem."},{"key":"10.1016\/j.cca.2024.120087_b0175","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1515\/cclm-2022-1250","article-title":"Development of a candidate reference measurement procedure by ID-LC-MS\/MS for total tau protein measurement in cerebrospinal fluid (CSF)","volume":"61","author":"Giangrande","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2024.120087_b0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cca.2015.10.014","article-title":"Performance of glycated hemoglobin (HbA1c) methods evaluated with EQAS studies using fresh blood samples: still space for improvements","volume":"451","author":"Mosca","year":"2015","journal-title":"Clin. Chim. Acta"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124023404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124023404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T18:42:02Z","timestamp":1737830522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124023404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"alternative-id":["S0009898124023404"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.120087","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization of hemoglobin A2 and hemoglobin F: Achievements and perspectives","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.120087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120087"}}